Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A most relevant question for patients diagnosed with Graves' hyperthyroidism, which occurs in a substantial number of subjects as the prevalence in the general population is in the order of 1% to 1.5% [1]
F1000Res, doi: 10.12688/f1000research.11775.1.
Generally safe, but medical clearance is required before treatment
ACK1 further phosphorylates AR at Y267, sustaining the oncogenic activity of acK609-AR and promoting the growth of castration-resistant prostate cancer (CRPC)
US$ 29.96
US$ 26.33
US$ 21.22
US$ 22.06
US$ 26.63
